<code id='CE8F441D42'></code><style id='CE8F441D42'></style>
    • <acronym id='CE8F441D42'></acronym>
      <center id='CE8F441D42'><center id='CE8F441D42'><tfoot id='CE8F441D42'></tfoot></center><abbr id='CE8F441D42'><dir id='CE8F441D42'><tfoot id='CE8F441D42'></tfoot><noframes id='CE8F441D42'>

    • <optgroup id='CE8F441D42'><strike id='CE8F441D42'><sup id='CE8F441D42'></sup></strike><code id='CE8F441D42'></code></optgroup>
        1. <b id='CE8F441D42'><label id='CE8F441D42'><select id='CE8F441D42'><dt id='CE8F441D42'><span id='CE8F441D42'></span></dt></select></label></b><u id='CE8F441D42'></u>
          <i id='CE8F441D42'><strike id='CE8F441D42'><tt id='CE8F441D42'><pre id='CE8F441D42'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:2376
          Darron Cummings/AP

          Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

          The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

          advertisement

          Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.
          Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

          RichardDrew/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsl

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          First Opinion on colorectal cancer screening: letter and response

          MollyFergusonforSTATToencouragerobust,good-faithdiscussionaboutdifficultissues,STATpublishesselected